Stock market announcement archive

May 21, 2024
Issuer: Lifecare ASAEx. date: 21 May 2024 Type of corporate action: Preferential rights issueOther information: The shares in Lifecare ASA will from today, 21 May 2024, be traded exclusive of the right to receive subscription rights for shares in the preferential rights issue announced on 25 April 2024.             This information is published in accordance with the requirements […]
Read more
May 16, 2024
The Extraordinary General Meeting of Lifecare ASA was convened as a hybrid meeting on 16 May 2024. All proposals on the agenda were adopted, cf. the notification of the Extraordinary General Meeting that was published on Oslo Stock Exchange on 2. May 2024. The complete minutes of the Extraordinary General Meeting are attached and will […]
Read more
May 15, 2024
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE’S REPUBLIC OF CHINA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. Reference is made to the stock exchange announcement published […]
Read more
May 13, 2024
Bergen, Norway, 29 April 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), announces that its conversion to a public limited liability company has been registered. Lifecare ASA’s conversion to a public limited liability company and corresponding name change from Lifecare AS to Lifecare ASA […]
Read more
May 7, 2024
Lifecare AS will present Q1 2024 financial and operational status in a webcast Wednesday 8 May. The webcast will be for all shareholders and interested parties at 11:00 – 11:45 CET. Lifecare’s CEO Joacim Holter presents the company’s Q1 report followed by a Q&A session where Holter will answer questions submitted in advance. Questions in […]
Read more
May 2, 2024
Lifecare AS will hold an Extraordinary General Meeting on May 16th, 2024, at 10:00 (CET). The notice with complete agenda and documents are available on https://lifecare.no/events/. It will be possible to attend the meeting in person or digitally through Orgbrain. Shareholders who wish to participate and vote at the Extraordinary General Meeting must be registered with […]
Read more
April 30, 2024
The Annual General Meeting of Lifecare AS was convened as a hybrid meeting on 30 April 2024. Trine Teigland (Board member) and Lutz Heinemann (Board member) were re-elected and Tone Kvåle (Board member) was elected as new member of the BoD as proposed by the Nomination Committee. No alternative candidates were proposed. All proposals on […]
Read more
April 29, 2024
Bergen, Norway, 29 April 2024: Lifecare AS (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), have invested NOK 2 million through a private placement in RemovAid AS, a medical technology company based in Oslo, Norway, after which Lifecare holds 81.1% of the shares in RemovAid. RemovAid has developed […]
Read more
April 26, 2024
Bergen, Norway 26 April 2024: Hannibal Invest AS, a company closely associated with Hans Hekland, member of the Board of Directors of LifeCare AS (the “Company”), has on 26 April 2024 sold 150,000 shares in the Company at an average price of NOK 3.05 per share. Following this transaction, Hannibal Invest AS holds 50,000 shares […]
Read more
April 26, 2024
Bergen, Norway, 26th April 2024: Lifecare AS (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), intend to invest NOK 2 million and become the majority shareholder in RemovAid AS, a medical technology company based in Oslo, Norway. RemovAid is an ISO 13485 certified company who specializes in the […]
Read more